Contract W81K0225FA145
The Republic Of Korea National Red Cross · Department Of Defense · September 16, 2025
The Republic Of Korea National Red Cross was awarded a federal contract by Department Of Defense (Department Of The Army) on September 16, 2025 for $9,000 of work in in-vitro diagnostic substance manufacturing. This is a task or delivery order issued under parent IDIQ W81K0222A0009. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 2, 2025.
Contract details
- PIID
- W81K0225FA145
- Parent IDIQ
- W81K0222A0009
- Award type
- Bpa Call
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- First action
- September 16, 2025
- Latest action
- December 2, 2025
Description
BLOOD PRODUCTS
Modification timeline
-
December 2, 2025Mod P00002 · Supplemental Agreement For Work Within Scope$8.8K
-
November 21, 2025Mod P00001 · Other Administrative Action$8.8K
-
September 16, 2025Base award$8.8K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W81K0225FA145?
Contract W81K0225FA145 is a federal contract awarded to The Republic Of Korea National Red Cross by Department Of Defense on September 16, 2025 for $9,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 2 times since the base award.
Who won contract W81K0225FA145?
The Republic Of Korea National Red Cross won contract W81K0225FA145 from Department Of Defense.
How much is contract W81K0225FA145 worth?
Contract W81K0225FA145 has obligated $9,000 to date.